Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis.

Rades D, Huttenlocher S, Šegedin B, Perpar A, Conde AJ, Garcia R, Veninga T, Stalpers LJ, Cacicedo J, Rudat V, Schild SE.

Int J Radiat Oncol Biol Phys. 2015 Jun 3. pii: S0360-3016(15)00604-5. doi: 10.1016/j.ijrobp.2015.05.042. [Epub ahead of print]

PMID:
26232852
2.

A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.

Rades D, Huttenlocher S, Veninga T, Bajrovic A, Bremer M, Rudat V, Schild SE.

Radiat Oncol. 2015 Apr 15;10(1):90. doi: 10.1186/s13014-015-0403-y.

3.

Re-irradiation of spinal cord compression due to metastasis in elderly patients.

Rades D, Evers JN, Bajrovic A, Veninga T, Schild SE.

Anticancer Res. 2014 May;34(5):2555-8.

PMID:
24778076
4.

Metastatic spinal cord compression: a validated survival score for elderly patients.

Rades D, Evers JN, Bajrovic A, Veninga T, Karstens JH, Schild SE.

Strahlenther Onkol. 2014 Oct;190(10):919-24. doi: 10.1007/s00066-014-0641-1. Epub 2014 Mar 22.

PMID:
24658606
5.

Number of involved extracranial organs predicts survival in patients with brain metastasis from small cell lung cancer.

Gerdan L, Šegedin B, Veninga T, Schild SE, Rades D.

Anticancer Res. 2013 Sep;33(9):3887-9.

PMID:
24023324
6.

A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone.

Rades D, Dziggel L, Nagy V, Segedin B, Lohynska R, Veninga T, Khoa MT, Trang NT, Schild SE.

Radiother Oncol. 2013 Jul;108(1):123-7. doi: 10.1016/j.radonc.2013.06.009. Epub 2013 Jul 3.

PMID:
23830191
7.

A validated scoring system to identify long-term survivors after radiotherapy for metastatic spinal cord compression.

Rades D, Veninga T, Bajrovic A, Karstens JH, Schild SE.

Strahlenther Onkol. 2013 Jun;189(6):462-6. doi: 10.1007/s00066-013-0342-1. Epub 2013 Apr 20.

PMID:
23604188
8.

Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer.

Rades D, Douglas S, Huttenlocher S, Veninga T, Bajrovic A, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Dec;188(12):1114-8. doi: 10.1007/s00066-012-0141-0. Epub 2012 Nov 1.

PMID:
23111468
9.

Impact of zoledronic acid on control of metastatic spinal cord compression.

Rades D, Hakim SG, Bajrovic A, Karstens JH, Veninga T, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Oct;188(10):910-6. Epub 2012 Aug 19.

PMID:
22903395
10.

A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer.

Rades D, Douglas S, Veninga T, Schild SE.

BMC Cancer. 2012 Jul 20;12:302. doi: 10.1186/1471-2407-12-302.

11.

A survival score for patients with metastatic spinal cord compression from prostate cancer.

Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJ, Hoskin PJ, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Sep;188(9):802-6. Epub 2012 Apr 25.

PMID:
22526228
12.

Prognostic factors for local control and survival in patients with spinal cord compression from myeloma.

Rades D, Douglas S, Veninga T, Poortmans P, Bajrovic A, Hoskin PJ, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Jul;188(7):628-31. doi: 10.1007/s00066-012-0077-4. Epub 2012 Mar 14.

PMID:
22410834
13.

Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.

Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJ, Hoskin PJ, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Jun;188(6):472-6. doi: 10.1007/s00066-012-0086-3. Epub 2012 Feb 25.

PMID:
22361746
14.

Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression.

Rades D, Douglas S, Veninga T, Stalpers LJ, Bajrovic A, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Apr;188(4):340-5. doi: 10.1007/s00066-011-0061-4. Epub 2012 Feb 23.

PMID:
22354333
15.

Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis.

Rades D, Kueter JD, Gliemroth J, Veninga T, Pluemer A, Schild SE.

Strahlenther Onkol. 2012 Feb;188(2):143-7. doi: 10.1007/s00066-011-0024-9. Epub 2012 Jan 12.

PMID:
22234538
16.

Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.

Rades D, Kueter JD, Meyners T, Pluemer A, Veninga T, Gliemroth J, Schild SE.

Clin Neurol Neurosurg. 2012 May;114(4):326-30. doi: 10.1016/j.clineuro.2011.10.042. Epub 2011 Dec 5.

PMID:
22152784
17.

Single brain metastasis: radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy.

Rades D, Hornung D, Veninga T, Schild SE, Gliemroth J.

Cancer. 2012 Jun 1;118(11):2980-5. doi: 10.1002/cncr.26612. Epub 2011 Oct 25.

18.

Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection.

Rades D, Veninga T, Hornung D, Wittkugel O, Schild SE, Gliemroth J.

Cancer. 2012 Feb 15;118(4):1138-44. doi: 10.1002/cncr.26379. Epub 2011 Jul 14.

19.

Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.

Rades D, Evers JN, Veninga T, Stalpers LJ, Lohynska R, Schild SE.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e469-73. doi: 10.1016/j.ijrobp.2011.01.058. Epub 2011 Apr 7.

PMID:
21477949
20.

Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.

Meyners T, Heisterkamp C, Kueter JD, Veninga T, Stalpers LJ, Schild SE, Rades D.

BMC Cancer. 2010 Oct 26;10:582. doi: 10.1186/1471-2407-10-582.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk